| 1st Nov 2017 7:00 am |
RNS |
AstraZeneca tralokinumab update in severe asthma |
| 31st Oct 2017 5:05 pm |
RNS |
US FDA approves AstraZeneca's Calquence for MCL |
| 23rd Oct 2017 7:05 am |
RNS |
AZ and MSD rapidly advance Lynparza in Japan |
| 23rd Oct 2017 7:00 am |
RNS |
US FDA approves Bydureon BCise for type-2 diabetes |
| 18th Oct 2017 7:00 am |
RNS |
FDA Priority Review for Lynparza in breast cancer |
| 17th Oct 2017 7:00 am |
RNS |
FDA accepts sBLA file for Imfinzi; priority review |
| 9th Oct 2017 7:00 am |
RNS |
FDA grants Tagrisso BTD for 1st-line EGFR nsclc |
| 2nd Oct 2017 3:00 pm |
RNS |
Total Voting Rights |
| 26th Sep 2017 12:00 pm |
RNS |
Director/PDMR Shareholding |
| 14th Sep 2017 7:00 am |
RNS |
Aspen acquires remaining rights to AZ anaesthetics |
| 11th Sep 2017 7:00 am |
RNS |
Tagrisso potential standard of care in lung cancer |
| 11th Sep 2017 7:00 am |
RNS |
IMFINZI superior PFS in Stage III lung cancer |
| 7th Sep 2017 12:39 pm |
RNS |
Celgene and AZ update on Fusion trial programme |
| 7th Sep 2017 7:00 am |
RNS |
AZ Duaklir improves lung function in COPD patients |
| 7th Sep 2017 7:00 am |
RNS |
AZ tezepelumab cuts exacerbations in severe asthma |
| 5th Sep 2017 7:00 am |
RNS |
Directorate Change |
| 1st Sep 2017 3:00 pm |
RNS |
Total Voting Rights |
| 29th Aug 2017 7:00 am |
RNS |
Faslodex gets US FDA OK for expanded use in breast |
| 18th Aug 2017 7:00 am |
RNS |
Lynparza gets broad FDA approval in ovarian cancer |
| 16th Aug 2017 7:00 am |
RNS |
Directorate Change |
| 14th Aug 2017 4:30 pm |
RNS |
Holding(s) in Company |
| 10th Aug 2017 1:30 pm |
RNS |
Publication of a Prospectus |
| 2nd Aug 2017 7:00 am |
RNS |
AZ acalabrutinib submission accepted by US FDA |
| 1st Aug 2017 3:00 pm |
RNS |
Total Voting Rights |
| 1st Aug 2017 7:00 am |
RNS |
BTD for AZ's acalabrutinib in mantle cell lymphoma |
| 31st Jul 2017 7:00 am |
RNS |
Imfinzi granted BTD by US FDA for Stage III nsclc |
| 28th Jul 2017 11:00 am |
RNS |
Director/PDMR Shareholding |
| 27th Jul 2017 7:15 am |
RNS |
Tagrisso significantly improves FLAURA |
| 27th Jul 2017 7:11 am |
RNS |
AZ reports initial results from MYSTIC lung trial |
| 27th Jul 2017 7:06 am |
RNS |
AZ & MERCK ESTABLISH STRATEGIC ONCOLOGY DEAL |
| 27th Jul 2017 7:00 am |
RNS |
AstraZeneca PLC - H1 2017 Results |
| 26th Jul 2017 4:46 pm |
RNS |
Faslodex receives EU approval for 1L breast cancer |
| 21st Jul 2017 3:45 pm |
RNS |
Holding(s) in Company |
| 3rd Jul 2017 2:59 pm |
RNS |
Total Voting Rights |
| 3rd Jul 2017 7:00 am |
RNS |
AZ COMPLETES SELOKEN AGREEMENT WITH RECORDATI |
| 3rd Jul 2017 7:00 am |
RNS |
AZ COMPLETES ZOMIG DIVESTMENT WITH GRÜNENTHAL |
| 23rd Jun 2017 12:46 pm |
RNS |
Faslodex CHMP positive opinion in 1L breast cancer |
| 7th Jun 2017 7:13 am |
RNS |
AZ agreement with Grünenthal for rights to Zomig |
| 6th Jun 2017 7:00 am |
RNS |
ASTRAZENECA PRICES A $2BN BOND ISSUE |
| 5th Jun 2017 7:00 am |
RNS |
LYNPARZA: SIGNIFICANT PFS IN BRCAm BREAST CANCER |
